Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd. on August 23, 2021, covering the month of August 2021. The filing serves to announce the date of the Company's annual shareholder meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance announcement and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
The Board of Directors approved the date for the Company's annual shareholder meeting, scheduled to be held on October 4, 2021. The information in this report is incorporated by reference into the Company's registration statements on Form F-3 (Registration Numbers 333-238988 and 333-239843). No specific financial guidance, risk factors, or unusual items are detailed in this filing.
Key Facts for Investor Verification
- Annual shareholder meeting date set for October 4, 2021.
- Report signed by Spiros Jamas, Sc.D., Chief Executive Officer and Director.
- Information incorporated by reference into active Form F-3 registration statements.
- No financial performance data included in this specific filing.